In a new study published in Clinical Gastroenterology and Hepatology, the low FODMAP diet and the antibiotic rifaximin ...
A BOWEL cancer trial stopped the disease in its tracks in all 32 patients who took part. After 33 months, 59 per cent of ...
This is the reality for the nearly 3.1 million Americans living with inflammatory bowel disease (IBD), including Crohn’s ...
Conventional wisdom holds that nonsteroidal anti-inflammatory drugs (NSAIDs) can trigger disease flares in patients with ...
Confused between IBS, acidity, and gas? Here's a simple guide to understanding the differences, symptoms, and causes so you ...
Celltrion, Inc. today announced that seven abstracts will be presented at the 2026 Digestive Disease Week® (DDW) Annual Meeting, taking place May 2-5 in Chicago, Illinois. The oral and poster ...
Hosted on MSN
Living well with inflammatory bowel disease
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, affects millions and can be unpredictable, painful, and exhausting. While there’s no cure yet, advances in ...
A new study found zero relapses among patients given a new treatment regime, with far better results than would be expected ...
LAS VEGAS, Nevada — Low-dose tricyclic antidepressant therapy is effective in treating moderately severe functional symptoms in patients with inflammatory bowel disease (IBD) who are not experiencing ...
The oral Janus kinase inhibitor upadacitinib was well tolerated for moderate to severe inflammatory bowel disease over a ...
Moderate-to-severe disability affects nearly one-third of patients with inflammatory bowel disease, according to a recent review.
NHS bowel cancer screening has now tested nearly 85million people for the disease and uptake has soared with the help of Sun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results